Janssen applies to US and EU for subcutaneous Darzalex
Janssen aims to expand the label of delivery in the US and EU for its product, Darzalex, to include subcutaneous delivery through the use of Halozyme’s technology.
Janssen aims to expand the label of delivery in the US and EU for its product, Darzalex, to include subcutaneous delivery through the use of Halozyme’s technology.
Drones deliver cold-chain medicines and vaccines to hard-to-reach areas by tapping into real-time data analysis in a pilot program.
Pall works with Servier to get the latter’s oncology drug production and biomanufacturing up and running to support its Bio-S project.